IHH Healthcare ‘on track’ for double-digit ROE despite medical inflation woes
Management says sustained medical inflation in Malaysia will stabilise over time
DeeperDive is a beta AI feature. Refer to full articles for the facts.
INTEGRATED healthcare operator IHH Healthcare is “on track for double-digit return on equity (ROE)” in the coming years, said its management on Friday (Feb 28).
While the group did not give a concrete timeline for achieving this goal, it has “set itself up for going towards double-digit ROE in 2025 as well”, said group chief financial officer Dilip Kadambi during an earnings call after the release of its FY2024 results.
ROE for FY2024 stood at 8.7 per cent, while ROE without exceptional items and the effects of Malaysian Financial Reporting Standard 129 – the financial reporting standard for hyperinflationary economies – was 9 per cent.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report